We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Looks to Ease Stakeholder Confusion Over UDI Direct Marking Requirements
FDA Looks to Ease Stakeholder Confusion Over UDI Direct Marking Requirements
The FDA is clarifying language related to the direct marking of medical devices for unique device identification purposes, including the definition of reprocessing.